Innovative use of point-of-care testing for chronic kidney disease screening

Point of Care

Volumn 10, Issue 2, 2011, Pages 98-101

  Shephard, Anne K ^a   Shephard, Mark D S ^a   Halls, Heather J ^a   Corso, Olivia ^b   Mathew, Timothy H ^b  

^a FLINDERS UNIVERSITY   (Australia)

^b Kidney Health Australia   (Australia)

Author keywords

chronic kidney disease; estimated glomerular filtration rate; isotope dilution mass spectrometry alignment; point of care testing

Indexed keywords

EID: 79958831894     PISSN: 1533029X     EISSN: 15330303     Source Type: Journal    
DOI: 10.1097/POC.0b013e31821c6bd0     Document Type: Article

References (19)

1. McDonald S, Excell L, Livingston B. Australia & New Zealand Dialysis and Transplant Registry (ANZDATA) 2008 Annual Report. Adelaide, South Australia: ANZDATA Registry; 2008.
2. Johnson DW. Evidence-based guide to slowing the progression of early renal insufficiency. Int Med J. 2004;34:50-57. (Pubitemid 38293697)
3. Briganti EM, Shaw JE, Chadban SJ, et al. Untreated hypertension among Australian adults: the 1999Y2000 Australian Diabetes, Obesity and Lifestyle Study (AusDiab). Med J Aust. 2003;179:135-139. (Pubitemid 37025189)
4. Mathew T, Corso O, Ludlow M, et al. Screening for chronic kidney disease in Australia: a pilot study in the community and workplace. Kidney Int. 2010;77(suppl 116):S9-S16.
5. Shephard MDS, Gill J. The national QAAMS program - a practical example of PoCT working in the community. Clin Biochem Rev. 2010;31:95-99.
6. Shephard M. Clinical and cultural effectiveness of the 'QAAMS' point-of-care testing model for diabetes management in Australian Aboriginal medical services. Clin Biochem Rev. 2006;27:161-170.
7. Shephard M, Shephard A, Watkinson L, et al. Design, implementation and results of the quality control program for the Australian Government's Point of Care Testing in General Practice Trial. Ann Clin Biochem. 2009;46:413-419.
8. Shephard M, Mazzachi B, Shephard A, et al. Point-of-care testing in Aboriginal hands - a model for chronic disease prevention and management in Indigenous Australia. Point Care. 2006;5:168-176.
9. Shephard M, Allen G, Paizis K, et al. Results of an Aboriginal community-based renal disease management program incorporating point of care testing for urine albumin:creatinine ratio [online]. Rural Remote Health. 2006;6:Article 591.
10. Shephard M, Mazzachi B, Shephard A, et al. The impact of point of care testing on diabetes services along Victoria's Mallee Track. Results of a community-based diabetes risk assessment and management program [online]. Rural Remote Health. 2005;5:371.
11. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis. 2002;39(suppl 2):S1-S246.
12. Peake M, Whiting M. Measurement of serum creatinine - current status and future goals. Clin Biochem Rev. 2006;27:173-184.
13. Bablok W, Passing H, Bender R, et al. A general regression procedure for method transformation. J Clin Chem Clin Biochem. 1988;26:783-790.
14. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurements. Lancet. 1986;i:307-310. (Pubitemid 16134762)
15. Levey AS, Coresh J, Greene T, et al. Using standardised serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Int Med. 2006;145:247-254. (Pubitemid 46768608)
16. Mathew T, Johnson DW, Jones GRD. Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: revised recommendation. Med J Aust. 2007;187:459-463.
17. Shephard M. Analytical goals for point-of-care testing used for diabetes management in Australian health care settings outside the laboratory. Point Care. 2006;5:177-185.
18. Brown WW, Peters RM, Ohmit SE, et al. Early detection of kidney disease in community settings: the Kidney Early Evaluation program (KEEP). Am J Kidney Dis. 2003;42:22-35. (Pubitemid 36807651)
19. Shephard MD, Peake MJ, Corso O, et al. Assessment of the Nova StatSensor whole blood point-of-care creatinine analyser for the measurement of kidney function in screening for chronic kidney disease. Clin Chem Lab Med. 2010;48:1113-1119.